Tag Archives: GlaxoSmithKline

Swine flu boost for GlaxoSmithKline

Posted on 01. May, 2009.

0

Shares in GlaxoSmithKline (GSK) rose 8 per cent this week after the outbreak of swine flu in Mexico increased demand for the company’s Relenza anti-viral drug. Shares in Swiss pharma group Roche, makers of Tamiflu, rose by a similar amount. But production headaches, stock-piles and the normally short duration of pandemics means that the companies [...]

Continue Reading